Parenteral Delivery of Peptides and Proteins - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 616

[494] Guodong C, Wei P, Hailiang G, Qinhua L, Yumin L, Frank RS, et al. In vivo delivery of
a Bcl-xL fusion protein containing the Tat protein transduction domain protects against
ischemic brain injury and neuronal apoptosis. J Neurosci 2002;22:5423-31.
[495] Schwarze SR, Ho A, Vocero-Akbani A, Steven FD. In vivo protein transduction: deliv-
ery of a biologically active protein into the mouse. Science 1999;285:1569-72.
[496] Harada H, Hiraoka M, Kizaka-Kondoh S. Antitumor effect of TAT-oxygen-dependent
degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic
tumor cells. Cancer Res 2002;62:2013-18.
[497] Kerkis A, Kerkis I, Rádis-Baptista G, Oliveira EB, Vianna-Morgante AM, Pereira LV,
et al. Crotamine is a novel cell-penetrating protein from the venom of rattlesnake
Crotalus durissus terrificus . FASEB J 2004;18:1407-9.
[498] Embury J, Klein D, Pileggi A, Ribeiro M, Jayaraman S, Molano RD, et al. Proteins
linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes
2001;50:1706-13.
[499] Kwon HY, Eum. WS, Jang HW, Kang JH, Ryu J, Ryong LB, et al. Transduction of Cu,
Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mamma-
lian cells. FEBS Lett 2000;485:163-7.
[500] Li HJ, Jae HB, Won SE, Hyeok YK, Sang HJ, Kyu HH, et al. Transduction of human
catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides
into mammalian cells. Free Radic Biol Med 2001;31:1509-19.
[501] Wheeler DS, Dunsmore KE, Wong HR. Intracellular delivery of HSP70 using HIV-1
Tat protein transduction domain. Biochem Biophys Res Commun 2003;301:54-9.
[502] Yoon HY, Lee SH, Cho SW, Lee JE, Yoon CS, Park J, et al. TAT-mediated delivery of
human glutamate dehydrogenase into PC12 cells. Neurochem Int 2002;41:37-42.
[503] Roeder GE, Parish JL, Stern PL, Gaston K. Herpes simplex virus VP22-human papillo-
mavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian
cells and induce apoptotic cell death. Biotechnol Appl Biochem 2004;40:157-65.
[504] Phelan A, Elliott G, O'Hare P. Intercellular delivery of functional p53 by the herpesvi-
rus protein VP22. Nat Biotechnol 1998;16:440-3.
[505] Anderson DC, Nichols E, Manger R, Woodle D, Barry M, Fritzberg AR. Tumor cell
retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-
derived peptide. Biochem Biophys Res Commun 1993;194:876-84.
[506] Masayasu M, Fumio T, Hisakage F, Yasuko Y, Masuo A, Kobatake E. Intracellular
delivery of antibodies using TAT fusion protein A. Biochem Biophys Res Commun
2003;310:730-4.
[507] Pamela M, Yasmin D, Blake P, David T, Steve F, James B. Tat-mediated protein
delivery can facilitate MHC class I presentation of antigens. Mol Biotechnol 1996;6:
105-13.
[508] Kim DT, Mitchel DJ, Brockstedt DG, Fong L, Nolan GP, Fathman CG, et al. Introduction
of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide.
J Immunol 1997;159:1666-8.
[509] URL1: active motif: tools to analyse nuclear function. http:// www.activemotif.com/cata-
log/37/chariot-protein-delivery-reagent/description.html . Accessed May 2010.
[510] Kim S. DepoFoam-mediated drug delivery into cerebrospinal fluid. J Neurosci Methods
1994;21:118-31.
[511] Kim T, Murdande S, Gruber A, Kim S. Sustained-release morphine for epidural analge-
sia in rats. Anesthesiology 1996;85:331-8.
[512] Kim S, Turker MS, Chi EY, Sela S, Martin GM. Preparation of multivesicular lipo-
somes. Biochim Biophys Acta 1983;728:339-48.